Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.77
Delayed Data
As of 4:00pm ET
 -0.10 / -3.48%
Today’s Change
1.82
Today|||52-Week Range
7.69
-24.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-43.0M-36.7M-38.0M-35.5M
 
 
 
 
 
Depreciation29.0K27.0K11.0K9.0K
 
 
 
 
 
Total Other Cash Flow2.7M2.9M5.2M3.3M
 
 
 
 
 
Funds From Operations-40.3M-33.7M-32.8M-32.1M
 
 
 
 
 
Funds From/For Other Operating Expenses2.9M5.0M4.1M4.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-43.2M-38.7M-37.0M-36.1M
 
 
 
 
 
 
InvestingIncrease In Investments-42.5M-35.7M-35.5M0.00
 
 
 
 
Decrease In Investments45.8M36.9M20.5M29.8M
 
 
 
 
 
Capital Expenditures-48.0K0.000.00-26.0K
 
 
 
Net Cash Flow Investing3.3M1.2M-15.0M29.7M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings0.000.0014.7M0.00
 
 
Long Term Debt Reduction-9.4M-1.6M-8.0M-7.6M
 
 
 
 
 
Net Proceeds Stock Sale56.3M43.8M26.4M32.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing46.9M42.2M33.1M25.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash7.1M4.7M-18.8M18.9M